Innovative Grade US Origin Mouse Plasma - CD-1 - June 15, 2017

Posted by Leanne Kodsman on

June 15, 2017 Innovative Research's Innovative Grade US Origin Mouse Plasma - CD-1 was recently used in the following study:

Preparation of tetrazine-containing 2 1 complexes of 99mTc and in vivo targeting using bioorthogonal inverse electron demand Diels-Alder chemistry

A Yazdani, N Janzen, S Czorny, R Ungard - Dalton Transactions, 2017
... 99mTc complexes 9b or 10b (100 L, 111 MBq) were added to pre-warmed (37 C) mouse plasma (900 L) (Innovative Research, Novi, MI), and the mixture vortexed prior to incubation at 37 C. At multiple time points (t=0, 0.25, 0.5, 1, 2, 3, 6 h), 100 L was removed and added ...

  • Tags: Animal Plasma, Innovative Grade US Origin Mouse CD1 Plasma

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!

    Related Posts

    Evaporation-Driven Water-in-Water Droplet Formation
    Single Donor Human Red Blood Cells from Innovative Research was used in the following s...
    Read the Article
    A Novel Method of High-Purity Extracellular Vesicle Enrichment from Microliter-scale Human Serum for Proteomic Analysis
    Pooled Human Serum Off The Clot from Innovative Research was used in the following stud...
    Read the Article
    Analysis of the Human Plasma Proteome Using Multi‐Nanoparticle Protein Corona for Detection of Alzheimer's Disease
    Single Donor Human Alzheimer's Plasma and Single Donor Human Plasma (Blood Derived) fro...
    Read the Article

    ← Older Post Newer Post →